Wenle Xia
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 18
- HER2/EGFR in Cancer Research 14
-
- Heat shock proteins research 6
- PI3K/AKT/mTOR signaling in cancer 5
- Ubiquitin and proteasome pathways 2
- Co-authors
- Neil L. Spector (23 shared papers)Lei-Hua Liu (12 shared papers)Sarah Bacus (9 shared papers)Richard Voellmy (6 shared papers)Krystal J. Alligood (1 shared paper)Robert J. Mullin (1 shared paper)Hong Ma (1 shared paper)Barry R. Keith (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Oncogene (3 papers)Breast Cancer Research (3 papers)Clinical Cancer Research (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Wenle Xia
31 papers receiving 2.7k citations
Wenle Xia's Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 1.7k
- Radiology, Nuclear Medicine and Imaging 709
- Genetics 251
- Molecular Biology 1.2k
- Aging 30
Countries citing papers authored by Wenle Xia
This map shows the geographic impact of Wenle Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenle Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenle Xia more than expected).
Fields of papers citing papers by Wenle Xia
This network shows the impact of papers produced by Wenle Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenle Xia. The network helps show where Wenle Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenle Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways Hit paper breakdown → | 2002 | 550 |
| 2 | 2006 | 291 | |
| 3 | 2005 | 291 | |
| 4 | 2005 | 211 | |
| 5 | 2004 | 198 | |
| 6 | 2006 | 127 | |
| 7 | 2007 | 120 | |
| 8 | 1997 | 117 | |
| 9 | 2013 | 115 | |
| 10 | 2008 | 88 | |
| 11 | 2007 | 88 | |
| 12 | 2000 | 70 | |
| 13 | 2013 | 54 | |
| 14 | 2007 | 51 | |
| 15 | 2010 | 44 | |
| 16 | Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas. | 1999 | 44 |
| 17 | 2011 | 42 | |
| 18 | 1998 | 41 | |
| 19 | 1999 | 36 | |
| 20 | 2000 | 32 |
About Wenle Xia
Wenle Xia is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Genetics and Physical and Theoretical Chemistry, having authored 31 papers that have together received 2.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (14 papers), Heat shock proteins research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), thermodynamics and calorimetric analyses (4 papers), Ubiquitin and proteasome pathways (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Oncology (1.7k citations), Radiology, Nuclear Medicine and Imaging (709 citations), Genetics (251 citations), Molecular Biology (1.2k citations) and Aging (30 citations). Wenle Xia has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Neil L. Spector, Lei-Hua Liu, Sarah Bacus, Richard Voellmy, Krystal J. Alligood, Robert J. Mullin, Hong Ma, Barry R. Keith, Gary Owens and David W. Rusnak. Their work appears in journals such as Proceedings of the National Academy of Sciences, Oncogene, Breast Cancer Research, Clinical Cancer Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.